相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance
Gabriela Nestal de Moraes et al.
CURRENT DRUG TARGETS (2016)
FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer
C. Gong et al.
ONCOGENE (2015)
The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma
Shu-Bin Gao et al.
JOURNAL OF HEPATOLOGY (2014)
Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses
Jung-Min Lee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
DNMT3B Overexpression by Deregulation of FOXO3a-Mediated Transcription Repression and MDM2 Overexpression in Lung Cancer
Yi-Chieh Yang et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
BRCA1 Pathway Function in Basal-Like Breast Cancer Cells
Sarah J. Hill et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
The mTOR Pathway Controls Cell Proliferation by Regulating the FoxO3a Transcription Factor via SGK1 Kinase
Shunsuke Mori et al.
PLOS ONE (2014)
Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation
Theodore Hu et al.
SCIENTIFIC REPORTS (2014)
BRCA1 is a negative modulator of the PRC2 complex
Lan Wang et al.
EMBO JOURNAL (2013)
Chromatin proteins and modifications as drug targets
Kristian Helin et al.
NATURE (2013)
BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers
Niamh E. Buckley et al.
NUCLEIC ACIDS RESEARCH (2013)
Foxo3a Expression Is a Prognostic Marker in Breast Cancer
Ying Jiang et al.
PLOS ONE (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance
Ana R. Gomes et al.
CHINESE JOURNAL OF CANCER (2013)
Forkhead box proteins: tuning forks for transcriptional harmony
Eric W. -F. Lam et al.
NATURE REVIEWS CANCER (2013)
Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin
Ka-Kei Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
C. T. Karadedou et al.
ONCOGENE (2012)
FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer
Hany Onsy Habashy et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia
Sylvain Thepot et al.
CELL CYCLE (2011)
DNA Methylome of Familial Breast Cancer Identifies Distinct Profiles Defined by Mutation Status
James M. Flanagan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
Martin Sauvageau et al.
CELL STEM CELL (2010)
Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer
Jie Chen et al.
PLOS ONE (2010)
BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells
Moltira Promkan et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
Tina Branscombe Miranda et al.
MOLECULAR CANCER THERAPEUTICS (2009)
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
Julian Puppe et al.
BREAST CANCER RESEARCH (2009)
Negative Regulation of AKT Activation by BRCA1
Tao Xiang et al.
CANCER RESEARCH (2008)
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis
Rui-Hong Wang et al.
MOLECULAR CELL (2008)
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Jer-Yen Yang et al.
NATURE CELL BIOLOGY (2008)
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis
Yiyu Zou et al.
BREAST CANCER RESEARCH (2008)
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27Kip1
EA Williamson et al.
ONCOGENE (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Novel Somatic Mutations in the BRCA1 Gene in Sporadic Breast Tumors
M Janatova et al.
HUMAN MUTATION (2005)
IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a
MCT Hu et al.
CELL (2004)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Breast cancer gene 1 (BRCA1): Role in cell cycle regulation and DNA repair-perhaps through transcription
K Somasundaram
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Prognostic importance of survivin in breast cancer
SM Kennedy et al.
BRITISH JOURNAL OF CANCER (2003)
5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation:: mechanistic studies and their implications for cancer therapy
JK Christman
ONCOGENE (2002)
Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27KIP1
PF Dijkers et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1
PF Dijkers et al.
CURRENT BIOLOGY (2000)
Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1
M Collado et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
